KRX:317450 Revenue

In the year 2025, Myung In Pharmaceutical LTD. had annual revenue of 287.25B KRW with 6.61% growth. Myung In Pharmaceutical LTD. had revenue of 72.09B in the quarter ending December 31, 2025, with 5.79% growth.

Revenue

287.25B

Revenue Growth

+6.61%

P/S Ratio

2.86

Revenue / Employee

857.48M

Employees

335

Market Cap

820.52B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	287.25B	17.82B	6.61%
Dec 31, 2024	269.43B	27.10B	11.18%
Dec 31, 2023	242.34B	16.51B	7.31%
Dec 31, 2022	225.83B	16.58B	7.92%
Dec 31, 2021	209.25B	21.41B	11.40%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
ImmuneOncia Therapeutics	111.21M
CellBion	1.95B
HEM Pharma	12.98B
DAE HWA Pharmaceutical	143.06B
NOVAREX	404.26B
GREEN CROSS WellBeing	164.68B
High Tech Pharm	70.18B
Vivozon Pharmaceutical	59.34B

Revenue Rankings